{
    "organizations": [],
    "uuid": "2b2103f9c66457a601a1616868c5d8186702fcb2",
    "author": "",
    "url": "https://www.reuters.com/article/brief-vericel-initiates-collaboration-wi/brief-vericel-initiates-collaboration-with-innovative-cellular-therapeutics-idUSFWN1OX0H6",
    "ord_in_thread": 0,
    "title": "BRIEF-Vericel Initiates Collaboration with Innovative Cellular Therapeutics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 2, 2018 / 1:17 PM / Updated 10 minutes ago BRIEF-Vericel Initiates Collaboration with Innovative Cellular Therapeutics Reuters Staff 1 Min Read \nJan 2 (Reuters) - Vericel Corp: \n* VERICEL CORP - ‍INITIATION OF LICENSE AGREEMENT WITH INNOVATIVE CELLULAR THERAPEUTICS FOLLOWING RECEIPT OF $5.1 MILLION UPFRONT,WARRANT PAYMENT FROM ICT​ \n* VERICEL - ‍UNDER DEAL,ICT WILL DEVELOP,DISTRIBUTE MACI EPICE,IXMYELOCEL-T,CARTICEL IN GREATER CHINA,SOUTH KOREA, SINGAPORE, OTHER COUNTRIES IN REGION​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-02T15:16:00.000+02:00",
    "crawled": "2018-01-02T15:36:42.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "initiate",
        "collaboration",
        "innovative",
        "cellular",
        "therapeutic",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "vericel",
        "corp",
        "vericel",
        "corp",
        "license",
        "agreement",
        "innovative",
        "cellular",
        "therapeutic",
        "following",
        "receipt",
        "million",
        "upfront",
        "warrant",
        "payment",
        "vericel",
        "deal",
        "ict",
        "develop",
        "distribute",
        "maci",
        "epice",
        "carticel",
        "greater",
        "china",
        "south",
        "korea",
        "singapore",
        "country",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}